Friday, December 23, 2011

Favorable Government Policies to Drive Indian Clinical Trial Market by Shushmul Maheshwari

According to our new research report “Booming Clinical Trials Market in India”, the clinical trial market in India has grown from a small segment to a fast growing sector. The Indian clinical trial market has been witnessing a chain of positive changes that will lead to a splendid growth in future. Favorable government policies, cost effective R&D climate and a large pool of skilled manpower are some of the prominent factors driving the Indian clinical trial market. On the back of these factors and some other development boosters, the market is expected to grow at a CAGR of 29% during 2009-2013.

The report has analyzed the Indian clinical trial market by emphasizing upon current market trends and growth drivers. For example – the pharma outsourcing market has been witnessing growth momentum due to clinical trial services being offered in India. Availability of skilled professionals and reasonable cost structure have prompted various healthcare providers and players to outsource their research activities.

“Booming Clinical Trials Market in India” covers those sections of the Indian clinical trial market that provide glimpse of the current market and future outlook. For example, sections like ‘clinical trial market overview’ and ‘cost analysis’ give all the necessary information of the global and Indian clinical trial market along with cost expenditure on phases (I-IV). Moreover, the services offered in India have been compared with key countries to provide an optimum outlook of the sector.

The report is an outcome of in-depth research and prudent analysis of the Indian clinical trial market. It utilizes some of the best techniques and methods to forecast sub-segments and related markets. Other than future forecast, the report provides a section on key Indian players and regulatory environment necessary to be described in order to complete the picture. The report has included all the necessary ingredients of the clinical trial market and will prove an effective resource for investment decision making.

For FREE SAMPLE of this report visit: